Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/01/2003CA2464943A1 Acarbose purification process
05/01/2003CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds
05/01/2003CA2464665A1 Diindolylmethane for the treatment of hpv infection
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464561A1 Methods of treatment using a gastric retained losartan dosage
05/01/2003CA2464403A1 Anthelmintic composition
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464311A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
05/01/2003CA2464290A1 Stents
05/01/2003CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction
05/01/2003CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464119A1 Antihistaminic/antitussive compositions
05/01/2003CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003CA2463923A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
05/01/2003CA2463902A1 Functionalized stilbene derivatives as improved vascular targeting agents
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
05/01/2003CA2463758A1 Salts formed of an at1-receptor antagonist and a cardiovascular agent
05/01/2003CA2463313A1 Stable composition comprising particles in a frozen aqueous matrix
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
05/01/2003CA2463309A1 Sterile, breathable patch for treating wound pain
05/01/2003CA2463282A1 Therapeutical agent for pruritus
05/01/2003CA2463226A1 Acetic acid derivatives
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2463043A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003CA2462714A1 Method for preparing heparin from mast cell cultures
05/01/2003CA2462250A1 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives
05/01/2003CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003CA2461661A1 Use of histamine to treat liver disease
05/01/2003CA2461545A1 Drugs comprising combination of triazaspiro¬5,5|undecane derivative with cytochrome p450 isozyme 3a4 inhibitor and/or p-glycoprotein inhibitor
05/01/2003CA2461182A1 Use of tyrosine kinase inhibitors for promoting hair growth
05/01/2003CA2461181A1 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
05/01/2003CA2461159A1 Imidazopyridine compounds as 5-ht4 receptor modulators
05/01/2003CA2461085A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
05/01/2003CA2460680A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
05/01/2003CA2458828A1 Optimized dosing for drug coated stents
05/01/2003CA2458542A1 Enzyme inhibitors for inactivating allergens
05/01/2003CA2458070A1 Method for re-sensitizing vancomycin resistant bacteria using agents which selectively cleave a cell wall depsipeptide
05/01/2003CA2429505A1 Prevention of recurrent viral disease
05/01/2003CA2428971A1 Conjugates of a therapeutic agent and a peptide carrier
04/2003
04/30/2003CN1414967A Silicon compounds derived from ascorbic acid, preparation method, composition containing the compounds and application
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones
04/30/2003CN1414963A Novel heteroary derivatives, their preparation and use
04/30/2003CN1414962A [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for treatment of central nervous system disorders
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414958A Nonpeptide substituted benzothiazepines as vasopressin antagonists
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/30/2003CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414951A Drug discharge pump inhibitors
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414946A Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxy cyclohexyl) phenyl
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414863A Treatment of DNA viral infections
04/30/2003CN1414862A Antidiabetic formulation and method
04/30/2003CN1414860A Treatment of infertility
04/30/2003CN1414859A Combinations for treatment of DNA viral infections
04/30/2003CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound
04/30/2003CN1414857A Treatment of drug-resistant human immunodeficiency virus infection
04/30/2003CN1414856A Antiprurity agents for external use
04/30/2003CN1414855A Remedies for external use for allergic skin diseases
04/30/2003CN1414854A Phosphonate compounds
04/30/2003CN1414853A Oral mucosal dosage forms of apomorphine
04/30/2003CN1414852A Novel composition and use thereof
04/30/2003CN1414851A Method and formulation for treating resistance to antihypertensives and related conditions
04/30/2003CN1414850A Preventive or therapeutic agent for inflammatory diseases of intestine
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1414848A Prevention of plaque rupure by ACAT inhibitors
04/30/2003CN1414847A Sustained-releasing antihelmintic compositions comprising praziquantel
04/30/2003CN1414846A Topical anti-microbial compositions
04/30/2003CN1414834A Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
04/30/2003CN1414101A Desmocyte growth factor 11
04/30/2003CN1414010A Cardiac glycoside type compound for treating carcinosis and its preparation method
04/30/2003CN1413734A Biological product for curing ulcerative colitis and preparation method
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413704A Huafeng pill
04/30/2003CN1413699A Drug for treating bronchial disease
04/30/2003CN1413689A Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel
04/30/2003CN1413685A Medicine for treating throat disease and stomatopathy
04/30/2003CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
04/30/2003CN1413608A Discorea nipponica and new use of its active component
04/30/2003CN1413600A Chinese medicine preparation containing ophiopogon root total saponin and preparation method
04/30/2003CN1413590A Cancer prevention oral medicine
04/30/2003CN1413589A Composition of paeoniflorin and albiflorin and its preparation method
04/30/2003CN1413588A Drug composition containing Fructus Tribuli fruit total saponin and its preparation method
04/30/2003CN1413587A Application of ganglioside in preparation of antiepileptic
04/30/2003CN1413586A Long-acting antiseptic injection for animal
04/30/2003CN1413585A Sodium penicillin for skin test
04/30/2003CN1413584A Antitumor oral medicine prepared by Chinese yew extract
1 ... 5486 5487 5488 5489 5490 5491 5492 5493 5494 5495 5496 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 ... 7860